Google DeepMind's SynthID Bio embeds a traceable mark in an AI-designed protein that a detector can find in the physical molecule, without changing how it works. The mark is meant to help DNA synthesis firms screen orders and trace which model made a sequence.
Reality
- Evidence54
- Adoption36
- Hype gap+12
- Incentives66
- Confidence55
buildConfirmed2 publishers Claude agents designed 1,440 protein binders and 354 bound. The interesting part is that the prompts, provenance and every measurement went out with the number.
Reality
- Evidence60
- Adoption30
- Hype gap+12
- Incentives68
- Confidence62
The saving comes off cache reads, so it lands unevenly across teams, and the model's most sensitive capability now reaches users through a credential issued by an access program, not a purchase order a budget holder can sign off alone. Both changes move the decision away from the budget holder.
Perspective Coverage
3 publishers
- Builder
- Builder 37%
- Operator
- Operator 25%
- Investor
- Investor 38%
Reality
- Evidence55
- Adoption30
- Hype gap+35
- Incentives65
- Confidence60
Anthropic's protein binders got tested by outside labs. The benchmark is still Anthropic's.
Two contract labs made and tested Claude's designs, which is genuinely new. The field baseline those results are scored against comes from the company that ran the experiment.
Reality
- Evidence42
- Adoption20
- Hype gap+25
- Incentives82
- Confidence45
buildOne report1 publisher That 34.3% TREM2 Hit Rate Belongs To Six Agents, Not To Claude
A one-day hackathon put agent-designed binders through Adaptyv Bio's wet-lab screen. The durable result is that the designs cleared a shared assay at all, not that any single model won.
Reality
- Evidence38
- Adoption14
- Hype gap+12
- Incentives66
- Confidence40